» Articles » PMID: 20525878

Hypoxia Inducible Factor-1 Mediates Expression of Galectin-1: the Potential Role in Migration/invasion of Colorectal Cancer Cells

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2010 Jun 8
PMID 20525878
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of galectin-1, one of the most important lectins participating in the malignant tumor development, has been shown to be regulated by hypoxia, but its exact mechanism remains elusive. Here, we find that ectopically expressed hypoxia-inducible factor (HIF) 1alpha protein, an oxygen-sensitive subunit of HIF-1 that is a master factor for cellular response to hypoxia, significantly increases galectin-1 expression in both messenger RNA and protein levels in all four colorectal cancer (CRC) cell lines tested. However, hypoxia-induced galectin-1 expression cannot be seen in sentrin/SUMO-specific protease 1 homozygous-null mouse embryonic fibroblasts that fail to accumulate HIF-1alpha protein. Furthermore, silence of HIF-1alpha or HIF-1beta expression by specific short hairpin RNAs (shRNAs) antagonizes hypoxia-induced galectin-1 expression. All these results propose that galectin-1 is a direct target of transcriptional factor HIF-1. Applying luciferase reporter assay and chromatin immunoprecipitation, we identify that two hypoxia-responsive elements located at -441 to -423 bp upstream to transcriptional start site of galectin-1 gene are essential for HIF-1-mediated galectin-1 expression. Finally, the knockdown of galectin-1 by its specific shRNA can significantly reduce hypoxia-induced invasion and migration of CRC cell line, and the ectopic expression of galectin-1 can remarkably restore invasion and migration abilities of HIF-1alpha-knocked SW620 cells, proposing that galectin-1 mediates the HIF-1-induced migration and invasion of CRC cells during hypoxia. Taken together, our results shed new light for understanding mechanism for hypoxia/HIF-1-mediated migration/invasion of CRC cells.

Citing Articles

Targeting Hypoxia and HIF1α in Triple-Negative Breast Cancer: New Insights from Gene Expression Profiling and Implications for Therapy.

Han D, Li Z, Luo L, Jiang H Biology (Basel). 2024; 13(8).

PMID: 39194515 PMC: 11351882. DOI: 10.3390/biology13080577.


Autophagy modulation attenuates sorafenib resistance in HCC induced in rats.

Elleithi Y, El-Gayar A, Amin M Cell Death Dis. 2024; 15(8):595.

PMID: 39152108 PMC: 11329791. DOI: 10.1038/s41419-024-06955-5.


Predicting Major Adverse Carotid Cerebrovascular Events in Patients with Carotid Stenosis: Integrating a Panel of Plasma Protein Biomarkers and Clinical Features-A Pilot Study.

Khan H, Zamzam A, Shaikh F, Saposnik G, Mamdani M, Qadura M J Clin Med. 2024; 13(12).

PMID: 38929911 PMC: 11203750. DOI: 10.3390/jcm13123382.


KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells.

Zheng Y, Zhang H, Xiao C, Deng Z, Fan T, Zheng B J Immunother Cancer. 2023; 11(8).

PMID: 37586772 PMC: 10432659. DOI: 10.1136/jitc-2023-007286.


Effect of RNAi-Mediated Survivin and Hypoxia-Inducible Factor 1α Gene Silencing on Proliferation, Invasion, Migration and Apoptosis of Gastric Cancer BGC-823 Cells.

Li Y, Liu Y, Chang M, Mu R, Zhu J Mol Biotechnol. 2023; 66(8):1872-1882.

PMID: 37440157 DOI: 10.1007/s12033-023-00786-z.